AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in congestive heart failure
18 avr. 2024 08h00 HE
|
Asklepios BioPharmaceutical, Inc. (AskBio)
Berlin, Germany, and Research Triangle Park, NC, USA, April 18, 2024 (GLOBE NEWSWIRE) -- Not intended for UK Media AB-1002 is being studied for the treatment of adults with non-ischemic...
Impulse Dynamics Announces Leadership Changes
19 sept. 2023 07h17 HE
|
Impulse Dynamics
MARLTON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, announced new leadership...
Daxor Corporation to Showcase the Benefits of BVA-100® Guided Care at the American Association of Heart Failure Nurses (AAHFN) 19th Annual Meeting
20 juin 2023 08h00 HE
|
Daxor Corporation
Oak Ridge, TN, June 20, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit at the American...
Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering
22 mai 2023 08h30 HE
|
Daxor Corporation
Oak Ridge, TN, May 22, 2023 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the pricing of...
Impulse Dynamics Announces First Implant for CCM-D™ Clinical Trial
18 mai 2023 07h30 HE
|
Impulse Dynamics
MARLTON, N.J., May 18, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, announced the completion of the...
Impulse Dynamics Announces 9,000th Patient Milestone Achieved With CCM® Therapy for Heart Failure
15 mai 2023 14h09 HE
|
Impulse Dynamics
MARLTON, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today a worldwide...
New Studies Presented at the 43rd International Society for Heart and Lung Transplant Validate the Applicability of the BVA-100® Blood Test for Patients with Advanced Heart Failure
20 avr. 2023 08h00 HE
|
Daxor Corporation
Study Demonstrates BVA Provides More Accurate Congestion Measurement in Challenging Patient Populations Oak Ridge, TN, April 20, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global...
New Data Advocates Shift to In-Home Healthcare, Casana Appoints VP of Research to Enhance Product Development
29 mars 2023 09h00 HE
|
Casana Care, Inc.
ROCHESTER, N.Y., March 29, 2023 (GLOBE NEWSWIRE) -- Today, Casana - the industry leader in monitoring heart health through smart toilets - announced that data from clinical study participants...
New Study Confirms Daxor’s BVA-100® Volume Metric Compared to CardioMEMS® Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients
23 mars 2023 08h30 HE
|
Daxor Corporation
Commonly Used Pressure Measure for Volume Assessment Discordant with Direct Measurement by BVA Oak Ridge, TN, March 23, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in...
Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients
23 mars 2023 08h00 HE
|
Daxor Corporation
BVA Feasibly Guides Fluid Management with Greater Accuracy than Traditional MeansResearchers Conclude that a Larger Powered RCT is Warranted Oak Ridge, TN, March 23, 2023 (GLOBE NEWSWIRE) -- Daxor...